Erikson Pharmaceuticals Private Limited
About Erikson Pharmaceuticals Private Limited
Data last updated:
Erikson Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 05 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U14101RJ1996PTC011517. Its GSTIN is 08AACCS5728G1Z9 (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Purushotam Dusad and Renu Dusad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 81 Nehru Nagar, Jaipur, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹24,246, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹13.75 Lakh and EBITDA of -₹13.6 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 86% over three years and 68% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 81 Nehru Nagar, Jaipur, Rajasthan, India
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Erikson Pharmaceuticals Private Limited
The main business activity of Erikson Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Erikson Pharmaceuticals Private Limited FY 2025 filings available
Erikson Pharmaceuticals Private Limited reported revenue of ₹24,246 (down 98% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Erikson Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 68% over five years, including a 98% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Erikson Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹13.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹13.75 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Erikson Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Erikson Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Purushotam Dusad Also directs: Laxmi Jagdish Hotels LLP, Nectar Biochem Private Limited, Maxis Bio Science Private Limited and 2 more | Director | 05 Feb 1996 | 30 Years 8 Months | Current |
| Renu Dusad Also directs: Nectar Biochem Private Limited, Sankalp Finstock Pvt Ltd | Director | 05 Feb 1996 | 30 Years 8 Months | Current |
Peer Comparison of Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ahantara Pharmaceuticals Private Limited | ₹24,859 (FY 2025) | •••• | •••• | •••• | Mohanlalganj, Uttar Pradesh, India | |
| Tirumala Surgical and Pharmaceuticals Private Limited | ₹24,710 (FY 2022) | •••• | •••• | •••• | Bhubaneswar, Odisha, India | |
| Mediscent Pharmaceuticals Private Limited | ₹24,500 (FY 2025) | •••• | •••• | -4.0% | •••• | Jankipuram Garden, Uttar Pradesh, India |
| John and Smith Pharmaceuticals Private Limited | ₹24,445 (FY 2018) | •••• | •••• | -97.0% | •••• | Muzaffarpur, Bihar, India |
| Lavenier Pharmaceuticals Private Limited | ₹24,360 (FY 2021) | •••• | •••• | -15.0% | •••• | Gopalganj, Bihar, India |
| Erikson Pharmaceuticals Private Limited this company | ₹24,246 (FY 2025) | •••• | •••• | -98.0% | •••• | Jaipur, Rajasthan, India |
| Rva Pharmaceuticals Private Limited | ₹24,085 (FY 2019) | •••• | •••• | -74.0% | •••• | Delhi, India |
| Camswin Pharmaceuticals Private Limited | ₹23,986 (FY 2024) | •••• | •••• | 10329.0% | •••• | Cuttack, Odisha, India |
| Rejuvin Pharmaceuticals Private Limited | ₹23,929 (FY 2025) | •••• | •••• | -73.0% | •••• | Kolkata, West Bengal, India |
| JRV Pharmaceuticals Private Limited | ₹23,059 (FY 2025) | •••• | •••• | -95.0% | •••• | Karnal, Haryana, India |
| Shuddha Pharmaceuticals Private Limited | ₹23,000 (FY 2025) | •••• | •••• | -85.0% | •••• | Pen, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Erikson Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals Private Limited is audited by Akar&Associates for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Akar&Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Erikson Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Erikson Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Erikson Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals Private Limited has 2 board changes on record since 1996: 2 appointments. The latest: Purushotam Dusad was appointed as Director on 05 Feb 1996.
Credit Ratings, Litigation & Regulatory Alerts for Erikson Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Erikson Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Erikson Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCS5728G1Z9 | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Erikson Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 05 February 1996 (30+ years old) and is registered under CIN U14101RJ1996PTC011517.
Erikson Pharmaceuticals reported revenue of ₹24,246 for FY 2025 (down 98% YoY).
Erikson Pharmaceuticals has 2 current directors:
- Purushotam Dusad - Director
- Renu Dusad - Director
Erikson Pharmaceuticals reported a net loss of ₹13.75 Lakh and EBITDA of -₹13.6 Lakh for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Erikson Pharmaceuticals is -86% over three years and -68% over five years. In the latest year (FY 2025) revenue fell 98%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Erikson Pharmaceuticals is 08AACCS5728G1Z9, registered in Rajasthan.
The CIN (Corporate Identification Number) of Erikson Pharmaceuticals is U14101RJ1996PTC011517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erikson Pharmaceuticals was incorporated on 05 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Erikson Pharmaceuticals by revenue are Ahantara Pharmaceuticals Private Limited, Tirumala Surgical and Pharmaceuticals Private Limited, Mediscent Pharmaceuticals Private Limited, John and Smith Pharmaceuticals Private Limited, Lavenier Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Purushotam Dusad was appointed as Director on 05 Feb 1996. Renu Dusad was appointed as Director on 05 Feb 1996.
The registered office of Erikson Pharmaceuticals is at B – 81 Nehru Nagar, Jaipur, Rajasthan, India.